Nasdaq
$21.84▲ 3.12%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $48.0MShares out 2.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
18- 9.24After-hours26.09.25 08:544/AOwnership#●●●
Apollomics Inc.
Apollomics Inc. insider Chen Yi-Kuei has filed a Form 4/A to amend the previously reported statement of changes in beneficial ownership of securities dated September 14, 2026. This filing serves to correct and update the details of the prior insider transaction report.…more
$21.84+3.12%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.24After-hours26.09.25 08:494/AOwnership
Apollomics Inc.
Apollomics Inc. insider LIN PETER KUAN-HOW has filed an amended Form 4/A to correct the statement of changes in beneficial ownership of securities for the reporting period of September 14, 2026. This filing reflects updates regarding the insider's stock ownership status.…more
$21.84+3.12%vs prev closeView filingShare - 9.24After-hours26.09.25 08:494/AOwnership
Apollomics Inc.
Apollomics Inc. insider Yen Hung Hsien has filed an amended statement of changes in beneficial ownership (Form 4/A). This filing serves to correct the reporting of the insider's equity holdings.…more
$21.84+3.12%vs prev closeView filingShare
17 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.11After-hours26.08.12 05:35#●●●#●●●
아폴로믹스, 1,000만 달러 규모 제3자 배정 유상증자 결정
아폴로믹스가 약 1,000만 달러 규모의 제3자 배정 유상증자를 통해 자금을 조달하며, 경영진이 직접 참여하여 지분을 확보했습니다. 이번 자금 조달은 신약 개발을 위한 운영 자금 확보 차원으로 해석됩니다.…more
$21.84+3.12%vs prev closeDetected5m · 30m · 60m · Next dayPLUS